Previous Close | 3.4820 |
Open | 3.4820 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's Range | 3.4820 - 3.4820 |
52 Week Range | 2.7500 - 4.9100 |
Volume | |
Avg. Volume | 1,737 |
Market Cap | 2.514B |
Beta (5Y Monthly) | 0.01 |
PE Ratio (TTM) | 29.02 |
EPS (TTM) | 0.1200 |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Key Insights a2 Milk's estimated fair value is NZ$11.35 based on 2 Stage Free Cash Flow to Equity a2 Milk is estimated...
a2 Milk (NZSE:ATM) has had a rough three months with its share price down 18%. However, stock prices are usually driven...
Investing in stocks inevitably means buying into some companies that perform poorly. But the long term shareholders of...
To get a sense of who is truly in control of The a2 Milk Company Limited ( NZSE:ATM ), it is important to understand...
Investors who take an interest in The a2 Milk Company Limited ( NZSE:ATM ) should definitely note that the Independent...
Does the December share price for The a2 Milk Company Limited ( NZSE:ATM ) reflect what it's really worth? Today, we...
a2 Milk's (NZSE:ATM) stock is up by 5.7% over the past three months. As most would know, long-term fundamentals have a...
New Zealand's a2 Milk Co Ltd has received U.S. approval to export its infant milk formula to the Unites States as the country faces a shortage of baby food. Under the approval from the U.S. Food and Drug Administration (FDA), the dairy major will be able to sell and distribute its a2 Platinum infant milk formula product through to Jan. 6, 2023, the company said on Thursday. The move will help plug a gap in baby food supply in the United States after Abbott Laboratories, the biggest U.S. supplier of powder infant formula, in February recalled dozens of products after reports of serious bacterial infections in four infants.
While not a mind-blowing move, it is good to see that the The a2 Milk Company Limited ( NZSE:ATM ) share price has...
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Full Year 2022 A2 Milk Company Ltd Earnings Call
New Zealand's A2 Milk Company Ltd said on Wednesday the U.S. Food and Drug Administration had deferred the dairy producer's request for an enforcement discretion to import infant milk formula products into the United States. A2 said it was informed by the International Dairy Foods Association that pending enforcement discretion applicants have also received similar communication from the FDA, indicating that the regulator is deferring any further review of all such applications at this time. Earlier this month, a2 dismissed a report suggesting that it was close to winning approval to sell baby formula in the United States, adding that the application was still under active review.
The company had in May confirmed an application to the U.S. Food and Drug Administration (FDA) seeking permission to supply baby food to the country. A2 Milk's stock price shot up as much as 12.2% to NZ$5.60 to hit its highest level since April 5. The media report suggested that FDA approval could be received "as soon as this week."
A look at the shareholders of The a2 Milk Company Limited ( NZSE:ATM ) can tell us which group is most powerful. Large...
In this article we are going to estimate the intrinsic value of The a2 Milk Company Limited ( NZSE:ATM ) by taking the...
(Reuters) -Dairy companies in Australia and New Zealand are queueing to restock empty shelves in the United States with baby food, after the country recently relaxed its import policy to mitigate one of the biggest infant formula shortages in recent history. New Zealand's dairy giants Fonterra and a2 Milk, and privately-run Australian firm Bellamy's Organic confirmed on Monday they had submitted applications to the U.S. Food and Drug Administration (FDA) for supplying baby food to the country. This followed fellow Antipodean firm Bubs Australia inking a deal with the FDA to ship at least 1.25 million cans of its formula.
New Zealand's a2 Milk Company said on Monday it had submitted an application to the U.S. Food and Drug Administration (FDA) to supply infant milk formula after Australian peer Bubs received the health agency's clearance last week. The Antipodean companies were looking to cash in on a relaxation of regulations around infant formula imports by the FDA earlier this month to mitigate one of the biggest baby food shortages in the United States in recent history. The crisis was triggered when Abbott Laboratories, the biggest U.S. supplier of powder infant formula including Similac, in February recalled dozens of products after reports of serious bacterial infections in four infants.
With its stock down 21% over the past three months, it is easy to disregard a2 Milk (NZSE:ATM). However, the company's...